Replies to post #3616 on Cerebain Biotech Corp (fka CBBT) (CBBT)

[mick]

INTERESTING MY FRIEND $CBBT

[mick]

READING FILING AND SHARE STRUCTURE---ANY CHANGE ????? $CBBT

[mick]

$CBBT / MGMT PRETTY COMPLETED---OTCQB Certification---in agreement very little dilution
https://www.otcmarkets.com/stock/CBBT/disclosure

I, Wesley D. Tate, Chief Financial Officer of Cerebain Biotech Corp. (“the Company”), certify that:
a. The Company is registered or required to file periodic reporting with the SEC or is exempt from SEC
registration as indicated below (mark the box below that applies with an “X”):
[ X ] Company is registered under Section 12(g) of the Exchange Act
[ ] Company is relying on Exchange Act Rule 12g3-2(b)
[ ] Company is a bank that reports to a Bank Regulator under Section 12(i) of the Exchange Act
[ ] Company is a bank that is non-SEC reporting but is current in its reporting to a Banking Regulator
[ ] Company is reporting under Section 15(d) of the Exchange Act.
[ ] Company is reporting under the Alternative Reporting Company Disclosure Guidelines
[ ] Other (describe)
b. The Company is current in its reporting obligations as of the most recent fiscal year end and any subsequent
quarters, and such information has been posted either on the SEC’s EDGAR system or the OTC Disclosure &
News Service, as applicable.
c. The Company Profile displayed on www.otcmarkets.com is current and complete as of September 26,2018 and
includes the total shares outstanding, authorized, and in the public float as of that date.
d. Please provide the following information as of the latest practicable date:
i. Number of Beneficial Owners holding at least 100 shares: 100 as of September 26, 2018
(“Beneficial Owner” shall mean any person who, directly or indirectly has or shares voting power of such
security or investment power, which includes the power to dispose, or to direct the disposition of, such
security.)
ii. Number of shares in the Public Float: 4,040,310 as of September 26, 2018
(“Public Float” shall mean the total number of unrestricted shares not held directly or indirectly by an officer,
director, any person who is the beneficial owner of more than 10 percent of the total shares outstanding, or
any Affiliates thereof, or any Immediate Family Members of officers, directors and control persons.)
e. The company is duly organized, validly existing and in good standing under the laws of Nevada in which the
Company is organized or does business.
f. Identify any law firm and attorney(s) that acted as the Company’s primary legal counsel in preparing its most
recent annual report. Include the firm and attorney(s) name if outside counsel, or name and title if internal counsel.
(If no attorney assisted in putting together the disclosure, the Company must identify the person or persons who
prepared the disclosure and their relationship to the company.) Please also identify any other attorney, if different
than the primary legal counsel, that assisted the company during the prior fiscal year on any matter including but
not limited to, preparation of disclosure, press releases, consulting services, corporate action or merger assistance,
etc.
Law Offices of Craig Butler, 300 Spectrum Center Drive, Suite 300, Irvine, CA 92618
g. The following is a complete list of third party providers, including names and addresses, engaged by the
Company, its officers, directors or controlling shareholders, during the period from the Company’s prior fiscal year
end to the date of this OTCQB Certification, to provide investor relations services, public relations services,
marketing, brand awareness, consulting, stock promotion, or any other related services to the Company.
OTC Markets Group Inc. March 14, 2018

NMS Capital Advisors, LLC, 433 North Camden Drive, 4th Floor, Beverly Hills, CA 90210
h. The following is a complete list of Officers, Directors and Control Persons (control persons are beneficial owners
of more than five percent (5%) of any class of the issuer’s equity securities), including name, address, and number
of shares owned. Options and warrants that can be converted into common shares within the next 60 days should
be included in the shareholdings listed below. If any of the beneficial shareholders are corporate entities, provide
the name and address of the person(s) owning or controlling such corporate entities.
Name Address (City and State only) Number of Shares Owned
Eric Clemons 600 Anton Blvd., Suite 1100,
Costa Mesa, CA 92626
1,439,122
Wesley Tate 600 Anton Blvd., Suite 1100,
Costa Mesa, CA 92626
914,203
Dr. Surinder Saini 1441 Avocado, Suite 807,
Newport Beach, CA 92660
825,000
Brad Vroom 4 Infinite Loop MS 304-2EB,
Cupertino, CA 95014
918,494
Jerrold Hinton 3768 Sarazen Cr., NE
Conover, NC 28613
960,003
Geronimo Middle East and Africa
(G.M.E.A.)
CAP 41 Bldg, 9th Floor
Dbayeh Hwy, Opposite ABC
Dbayeh, El Metn
Mount Lebanon, Lebanon
528,000
Date: September 26, 2018
Name of Certifying CEO or CFO: Wesley D. Tate
Title: Chief Financial Officer
Signature: /s/ Wesley D. Tate
(Digital Signatures should appear as “/s/ [OFFICER NAME]”)

[mick]

I THINK SHAREHOLDER COUNT IS HIGHER TODAY $CBBT

[mick]

TOTALLY LIKE SS \\\\\///// $CBBT SECURITY DETAILS
Share Structure
Market Cap Market Cap
481,100
07/17/2019

Authorized Shares
1,250,000,000
07/17/2019

Outstanding Shares
336,677,658
07/17/2019

Restricted
5,529,037
07/17/2019

Unrestricted
331,148,621
07/17/2019

Held at DTC
329,644,120
07/17/2019

Float
4,040,310
09/26/2018

Par Value
No Par Value
Market Value calculated only for respective security
Transfer Agent
Transfer Online, Inc.
Shareholders
Shareholders of Record 122
09/26/2018

[Golden Cross]

8-K

https://www.otcmarkets.com/filing/html?id=13547925&guid=CSXIUH_UxlDvJth

[mick]

where is 2019 ????? late filer ?????'Cerebain Biotech Corp. (CBBT)'

re;
$CBBT Current Filings and Share Structure:

Current Filings:
https://www.otcmarkets.com/stock/CBBT/disclosure

Current Share Structure:
https://www.otcmarkets.com/stock/CBBT/security

[mick]

are $CBBT filings usually on time, interesting pps closing..

re;
$CBBT Current Filings and Share Structure:

Current Filings:
https://www.otcmarkets.com/stock/CBBT/disclosure

Current Share Structure:
https://www.otcmarkets.com/stock/CBBT/security

[mick]

reading $CBBT/SEC Filings/8-K 07/23/2019 07/01/2019 PDFRTFHTMLXLS

https://www.otcmarkets.com/stock/CBBT/disclosure

FORM TYPE RECEIVED PERIOD END DATE REPORT
8-K 07/23/2019 07/01/2019 PDFRTFHTMLXLS
10-Q 05/20/2019 03/31/2019 PDFRTFHTMLXLS
NT 10-Q 05/16/2019 03/31/2019 PDFRTFHTMLXLS
DEF 14C 04/22/2019 04/22/2019 PDFRTFHTMLXLS
8-K 04/05/2019 03/01/2019 PDFRTFHTMLXLS
PRE 14C 04/05/2019 04/05/2019 PDFRTFHTMLXLS
10-Q 02/19/2019 12/31/2018 PDFRTFHTMLXLS
NT 10-Q 02/15/2019 12/31/2018 PDFRTFHTMLXLS
SC 13G 02/15/2019 PDFRTFHTMLXLS
8-K 12/26/2018 12/10/2018 PDFRTFHTMLXLS

[mick]

#2/$CBBT/SEC Filings/8-K 07/23/2019 07/01/2019 PDFRTFHTMLXLS

https://www.otcmarkets.com/stock/CBBT/disclosure


SEC Filings
FORM TYPE RECEIVED PERIOD END DATE REPORT
8-K 07/23/2019 07/01/2019 PDFRTFHTMLXLS
10-Q 05/20/2019 03/31/2019 PDFRTFHTMLXLS
NT 10-Q 05/16/2019 03/31/2019 PDFRTFHTMLXLS
DEF 14C 04/22/2019 04/22/2019 PDFRTFHTMLXLS
8-K 04/05/2019 03/01/2019 PDFRTFHTMLXLS
PRE 14C 04/05/2019 04/05/2019 PDFRTFHTMLXLS
10-Q 02/19/2019 12/31/2018 PDFRTFHTMLXLS
NT 10-Q 02/15/2019 12/31/2018 PDFRTFHTMLXLS
SC 13G 02/15/2019 PDFRTFHTMLXLS
8-K 12/26/2018 12/10/2018 PDFRTFHTMLXLS